In continuation to earlier intimation dated November 19, 2024, informing about notice of Postal Ballot dated November 12, 2024 seeking approval of members of the Company in respect of the items set out in the Notice through remote e-voting system and based on the scrutinizer report dated December 20, 2024, all the resolution as set out in the Notice of Postal Ballot, have been passed with requisite majority by the members of the Company. In this regard, Valiant Laboratories has informed that it enclosed: Details of voting results of the Postal Ballot conducted through electronic means in prescribed format pursuant to Regulation 44 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 and Scrutinizer's Report on Postal Ballot. The voting results and the Scrutinizer's Report are being uploaded on the Company's website at www.valiantlabs.in and on the website of National Securities Depository (NSDL) www.evoting.nsdl.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: